Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 13 de 13
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Stroke Cerebrovasc Dis ; 31(11): 106729, 2022 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-36116220

RESUMO

OBJECTIVES: Growing evidence suggests breast cancer susceptibility gene (BRCA) mutations may augment cerebrovascular risk factors. With this influence in mind, we aimed to identify if BRCA mutations increased the prevalence of cerebral small vessel disease (CSVD). METHODS AND MATERIALS: We performed a retrospective cross-sectional analysis of adults undergoing malignancy evaluation with confirmed BRCA mutations compared to BRCA wildtype individuals. A standard-of-care brain MRI was reviewed. Chi-squared or Fisher's, Wilcoxon rank-sum and the Student's t-test analyses were used when appropriate. Adjusted logistic regression models were fit to calculate odds ratio. Multicollinearity was tested by variance inflation factor calculation and for goodness-of-fit via the Hosmer-Lemeshow test. RESULTS: Of 116 individuals, 44.8% (52/116) carried a BRCA mutation. Demographic and cerebrovascular risk factors did not differ. Cerebral microbleeds were more common in those with BRCA mutation: [32.7% (17/52) vs. 17.2% (11/64), p = 0.05] with an adjusted odds ratio of 2.8 (95%CI 1.08-6.89, p = 0.03). Other markers of CSVD were similar amongst the cohort. CONCLUSIONS: We identified a nearly 3-fold increase in identified cerebral microbleed in those with BRCA mutations compared with BRCA wildtype individuals suggestive of an interaction between the BRCA gene and cerebral microbleed formation. Further studies are needed to confirm our findings and to understand clinical implications.


Assuntos
Neoplasias da Mama , Doenças de Pequenos Vasos Cerebrais , Adulto , Humanos , Feminino , Projetos Piloto , Estudos Retrospectivos , Estudos Transversais , Neoplasias da Mama/genética , Mutação , Hemorragia Cerebral/diagnóstico por imagem , Hemorragia Cerebral/epidemiologia , Hemorragia Cerebral/genética
2.
J Stroke Cerebrovasc Dis ; 30(11): 106065, 2021 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-34455151

RESUMO

BACKGROUND: Hyperglycemia is common after acute ischemic stroke and is associated with worse outcome, but intensive glucose control has not improved outcome. There is also a racial disparity in outcome after stroke, with Black patients more likely to have functional impairment than whites. We aimed to evaluate if there were racial differences in outcomes in acute ischemic stroke patients treated with intensive glucose control. METHODS: We performed a post-hoc analysis of the Stroke Hyperglycemia Insulin Network Effort (SHINE) trial to determine if Black patients had worse functional outcome than whites and if standard versus intensive glucose control modified that association. We included non-Hispanic white and Black patients. The primary outcome was excellent functional outcome (90-day modified Rankin Score of 0-1). To account for patient clustering by study site, we fit mixed-effects logistic regression models to our outcome and tested the interaction of treatment and race. RESULTS: We included 895 patients, of which 304 (34%) were Black and 591 (66%) were white. The rate of excellent outcome was 31.6% in Black patients versus 41.0% in white patients (p=0.006). After adjusting for potential confounders, the odds ratio for excellent outcome in Black patients was 0.54 (95% CI 0.38-0.77). The interaction term between treatment and race was significant (p=0.067). In the intensive treatment arm, Black patients had a predicted probability of excellent outcome of 26.4% (20.1-32.8) versus 42.7% (37.6-47.9) for white patients (p<0.001), while in the standard treatment arm the difference was not significant. CONCLUSIONS: Black patients with acute ischemic stroke and hyperglycemia had worse functional outcome at 90 days than white patients, particularly if given intensive glucose control. These findings are from a post-hoc analysis and may be confounded, thus warrant additional study.


Assuntos
Negro ou Afro-Americano , Disparidades nos Níveis de Saúde , Hiperglicemia , AVC Isquêmico , Negro ou Afro-Americano/estatística & dados numéricos , Humanos , Hiperglicemia/tratamento farmacológico , Hiperglicemia/etnologia , Hipoglicemiantes/uso terapêutico , AVC Isquêmico/etnologia , Resultado do Tratamento , População Branca/estatística & dados numéricos
6.
Am J Hosp Palliat Care ; 34(5): 466-469, 2017 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-27034434

RESUMO

OBJECTIVES: To describe the CARES program, a model of palliative care for nursing home residents. DESIGN: Descriptive analysis of the Caring About Residents' Experiences and Symptoms (CARES) Program that provides palliative care services to nursing home residents. PROGRAM EVALUATION: The CARES Program serves as an example of collaborative efforts to meet community needs. To evaluate the program, we document the services provided as well as process outcomes (changes to care plans, hospitalizations, location of death, and hospice utilization) for residents referred. RESULTS: 170 nursing home residents were seen by CARES Program between February 2013 to December 2015, 48% for skilled services, and 52% for long term care. Majority of referrals were for goals of care and concurrent symptom management. Following consultation, 67% of residents had a change in code status. Of residents desiring a palliative course 90% were never hospitalized. Overall, 53% of residents died; and those in long term care dying more often with hospice. CONCLUSION: The CARES program of palliative consultation addresses the needs of nursing home residents. The model has potential to be reproducible in in other communities.


Assuntos
Instituição de Longa Permanência para Idosos/organização & administração , Casas de Saúde/organização & administração , Cuidados Paliativos/organização & administração , Adulto , Idoso , Idoso de 80 Anos ou mais , Feminino , Cuidados Paliativos na Terminalidade da Vida/estatística & dados numéricos , Hospitalização/estatística & dados numéricos , Humanos , Masculino , Pessoa de Meia-Idade , Avaliação de Processos e Resultados em Cuidados de Saúde , Planejamento de Assistência ao Paciente/organização & administração
7.
Am J Hosp Palliat Care ; 34(2): 132-134, 2017 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-26341104

RESUMO

BACKGROUND: While many patients hope to die at home, many die in hospitals. Patients die with unrecognized and untreated symptoms including dyspnea. OBJECTIVE: We sought to determine prevalence of dyspnea at end of life in patients dying in acute hospital care and examine treatment patterns. DESIGN/PARTICIPANTS: A retrospective chart review of deaths at tertiary care hospital over a 3-month period evaluated dyspnea in last 24 hours of life, opioid orders and administration as well as presence of palliative care consultation. RESULTS: Of 106 decedents, 88 experienced dyspnea or tachypnea in last 24 hours of life. Health care providers noted only 50% as dyspneic, even those undergoing terminal comfort extubation. Almost all patients with dyspnea documented by staff had orders and received opioids; however, few orders described treatment specifically for dyspnea. Patients with palliative care consultations more often received opioids ( P = .0007), and opioid orders more often specified treatment of dyspnea ( P = .013). CONCLUSION: These findings support that previous work noting many patients experience dyspnea at end of life. Despite national guidelines, health care providers may still be underrecognizing and likely not optimally treating dyspnea at the end of life in the hospital. Collaboration with palliative medicine providers may improve assessments and treatments for quality end-of-life care for hospitalized patients.


Assuntos
Dispneia/mortalidade , Hospitalização/estatística & dados numéricos , Analgésicos Opioides/uso terapêutico , Dispneia/epidemiologia , Dispneia/terapia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Cuidados Paliativos/estatística & dados numéricos , Prevalência , Estudos Retrospectivos , Assistência Terminal/estatística & dados numéricos
8.
Cleve Clin J Med ; 83(6): 443-51, 2016 06.
Artigo em Inglês | MEDLINE | ID: mdl-27281257

RESUMO

Older adults compose a large portion of patients with persistent pain. Opioid analgesics are widely used to treat acute and persistent pain in cancer and end-of-life care, but their use in other types of persistent pain in older adults is controversial. Clinicians and regulators must work together, balancing the legitimate medical need for opioids while acknowledging increasing opioid misuse and morbidity and mortality related to opioids.


Assuntos
Analgésicos Opioides/uso terapêutico , Dor Crônica/tratamento farmacológico , Manejo da Dor/métodos , Idoso , Idoso de 80 Anos ou mais , Feminino , Humanos , Masculino , Uso Excessivo de Medicamentos Prescritos
10.
J Pain ; 8(2): 152-60, 2007 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-16949879

RESUMO

UNLABELLED: Chronic pain is a major health issue that causes significant patient morbidity as well as economic loss. Many studies have highlighted the lack of training in chronic pain management for resident physicians and the need to develop programs that address the challenges of providing care to chronic pain patients. We wanted to determine whether a workshop using a combination of standardized patients, small groups, and large group lectures addresses residents' curricular needs regarding chronic pain management. We developed a 1-day workshop for residents at Eastern Virginia Medical School, which has a nationally recognized professional skills center. After completing the workshop, residents showed significant gains in knowledge (post-test vs pre-test overall mean +23.4%, P < .001). Significant gains in clinical skills were also seen (overall +5.9%, P < .001) with improvements in the areas of pain assessment (+6.3%, P < .001), physical examination (+7.7%, P < .03), and pain management (+8%, P < .01). Physicians also reported increased comfort regarding chronic pain management. Almost all residents stated they would make specific practice changes in the assessment and management of chronic pain patients. The results suggest our workshop is a novel model that is effective in teaching residents how to assess and manage chronic pain. PERSPECTIVE: This article demonstrates that the use of standardized patients with other teaching methods is an effective approach in teaching resident physicians regarding the assessment and management of chronic pain patients. The findings have the potential to restructure our methods of teaching in chronic pain education.


Assuntos
Educação de Pós-Graduação em Medicina/métodos , Internato e Residência/métodos , Corpo Clínico Hospitalar/educação , Manejo da Dor , Dor/diagnóstico , Centros Médicos Acadêmicos , Doença Crônica , Currículo , Educação/métodos , Avaliação Educacional , Feminino , Humanos , Masculino
12.
Consult Pharm ; 20(9): 722-33, 2005 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-16548665

RESUMO

Difficulty eating is one of the markers of end-stage dementia and poses difficult care decisions for family members and health care providers. In particular, family members often struggle with the decision of whether to provide artificial nutrition via feeding tube. While it is important that surrogate decision makers be provided with information on the risks and benefits of artificial nutrition, studies have shown that many health care providers are misinformed about the rationale for recommending a percutaneous endoscopic gastrostomy tube. Current literature suggests that for the elderly patient with dementia there is little clinical evidence that artificial nutrition provides any benefit to the patient.

13.
Compr Ther ; 29(1): 43-6, 2003.
Artigo em Inglês | MEDLINE | ID: mdl-12701342

RESUMO

Persistent pain is a challenging problem in the elderly and is not a normal process in aging. Successful management of persistent pain can be achieved through comprehensive assessment, use of routine pain medication and careful monitoring of medical functional status.


Assuntos
Dor Intratável/terapia , Idoso , Analgésicos/uso terapêutico , Quimioterapia Adjuvante/métodos , Humanos , Dor/classificação , Medição da Dor/métodos , Dor Intratável/diagnóstico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...